Newlink Genetics reported -7731000 in EBIT for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Intrexon XON:US $ -25469000 10.34M
Nektar Therapeutics NKTR:US $ -112910000 686K
Newlink Genetics NLNK:US -7731000 1.16M
Prothena PRTA:US -37944000 4.85M